These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28454057)

  • 1. Application of 2D-NMR with room temperature NMR probes for the assessment of the higher order structure of filgrastim.
    Brinson RG; Ghasriani H; Hodgson DJ; Adams KM; McEwen I; Freedberg DI; Chen K; Keire DA; Aubin Y; Marino JP
    J Pharm Biomed Anal; 2017 Jul; 141():229-233. PubMed ID: 28454057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2D J-correlated proton NMR experiments for structural fingerprinting of biotherapeutics.
    Brinson RG; Marino JP
    J Magn Reson; 2019 Oct; 307():106581. PubMed ID: 31499472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Natural Isotopic Abundance ¹H-¹³C- and ¹H-¹⁵N-Correlated Two-Dimensional NMR for Evaluation of the Structure of Protein Therapeutics.
    Arbogast LW; Brinson RG; Marino JP
    Methods Enzymol; 2016; 566():3-34. PubMed ID: 26791974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Order Structure Differences Among Insulin Crystalline Drugs Revealed by 2D heteronuclear NMR.
    Wang S; Rienstra CM; Chen K
    ChemMedChem; 2024 Aug; ():e202400340. PubMed ID: 39116305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best Practices in Utilization of 2D-NMR Spectral Data as the Input for Chemometric Analysis in Biopharmaceutical Applications.
    Brinson RG; Arbogast LW; Marino JP; Delaglio F
    J Chem Inf Model; 2020 Apr; 60(4):2339-2355. PubMed ID: 32249579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher-Order Structure Characterization of Pharmaceutical Proteins by 2D Nuclear Magnetic Resonance Methyl Fingerprinting.
    Haxholm GW; Petersen BO; Malmstrøm J
    J Pharm Sci; 2019 Sep; 108(9):3029-3035. PubMed ID: 31082403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR Methods.
    Poppe L; Jordan JB; Rogers G; Schnier PD
    Anal Chem; 2015 Jun; 87(11):5539-45. PubMed ID: 25929316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical techniques and bioactivity assays to compare the structure and function of filgrastim (granulocyte-colony stimulating factor) therapeutics from different manufacturers.
    Levy MJ; Gucinski AC; Sommers CD; Ghasriani H; Wang B; Keire DA; Boyne MT
    Anal Bioanal Chem; 2014 Oct; 406(26):6559-67. PubMed ID: 24264620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the higher order structure of Humira®, Remicade®, Avastin®, Rituxan®, Herceptin®, and Enbrel® by 2D-NMR fingerprinting.
    Hodgson DJ; Ghasriani H; Aubin Y
    J Pharm Biomed Anal; 2019 Jan; 163():144-152. PubMed ID: 30296716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR based quality evaluation of mAb therapeutics: A proof of concept higher order structure biosimilarity assessment of trastuzumab biosimilars.
    Joshi S; Khatri LR; Kumar A; Rathore AS
    J Pharm Biomed Anal; 2022 May; 214():114710. PubMed ID: 35290923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products.
    Wang D; Zhuo Y; Karfunkle M; Patil SM; Smith CJ; Keire DA; Chen K
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate Analysis of Two-Dimensional
    Arbogast LW; Delaglio F; Schiel JE; Marino JP
    Anal Chem; 2017 Nov; 89(21):11839-11845. PubMed ID: 28937210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the structure of pegylated-recombinant protein therapeutics by the NMR fingerprint assay.
    Hodgson DJ; Aubin Y
    J Pharm Biomed Anal; 2017 May; 138():351-356. PubMed ID: 28254519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An NMR-Based Similarity Metric for Higher Order Structure Quality Assessment Among U.S. Marketed Insulin Therapeutics.
    Wang D; Park J; Patil SM; Smith CJ; Leazer JL; Keire DA; Chen K
    J Pharm Sci; 2020 Apr; 109(4):1519-1528. PubMed ID: 31927041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics.
    Perodeau J; Arbogast LW; Nieuwkoop AJ
    Mol Pharm; 2023 Mar; 20(3):1480-1489. PubMed ID: 36702622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies.
    Japelj B; Ilc G; Marušič J; Senčar J; Kuzman D; Plavec J
    Sci Rep; 2016 Aug; 6():32201. PubMed ID: 27578487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the 2D
    Hwang TL; Batabyal D; Knutson N; Wikström M
    Molecules; 2021 May; 26(9):. PubMed ID: 34063095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR.
    Aubin Y; Hodgson DJ; Thach WB; Gingras G; Sauvé S
    Pharm Res; 2015 Oct; 32(10):3365-75. PubMed ID: 26043856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principal Component Analysis of 1D 1H Diffusion Edited NMR Spectra of Protein Therapeutics.
    Elliott KW; Delaglio F; Wikström M; Marino JP; Arbogast LW
    J Pharm Sci; 2021 Oct; 110(10):3385-3394. PubMed ID: 34166704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.